Danaher Corp.
http://www.danaher.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Danaher Corp.
Medtech’s Leading Revenue Earners In 2023: Johnson & Johnson Tops $30bn
Abbott’s weaker rapid diagnostic sales see the erstwhile industry leader slip down the global 2023 medtech rankings, while Johnson & Johnson passes it on the way up on the back of strong external and internal growth.
Medtech’s Leading Revenue Earners In 2023: Johnson & Johnson Tops $30bn
Abbott’s weaker rapid diagnostic sales see the erstwhile industry leader slip down the global 2023 medtech rankings, while Johnson & Johnson passes it on the way up on the back of strong external and internal growth.
Bespoke Gene Therapy ‘Playbook’ Outlines Platform Approach To AAV-Based Treatments
Supporting ‘n of 1’ gene therapy development, the playbook from a Foundation for the National Institutes of Health-backed consortium aims to help investigators who are not traditional product sponsors prepare for meetings with US FDA and IND submissions.
The John Green Effect: Will Industry Be Influenced Again?
Drug and device makers regularly use media to sway consumers. But some advocacy groups recently turned the tables by using social media to sway industry.
Company Information
- Industry
- In Vitro Diagnostics
- Medical Devices
- Research, Analytical Equipment & Supplies
- Other Names / Subsidiaries
-
- Beckman Coulter
- Cepheid
- Cytiva
- GE Life Sciences
- Hybritech
- Pall Corporation
- Radiometer Medical ApS
- HemoCue AB
- Integrated DNA Technologies, Inc.
- Leica Microsystems Inc.
- Leica Biosystems Inc.
- Vision Systems Ltd.
- Coretech Holdings, LLC
- Q3DM Inc.
- Aldevron LLC
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice